Bayesian survival analysis in clinical trials: What methods are used in practice? - Wikidata - wikimedia - TriplyDB

Bayesian survival analysis in clinical trials: What methods are used in practice?

Bayesian survival analysis in clinical trials: What methods are used in practice?

http://www.wikidata.org/entity/Q38978314

about

Bayesian survival analysis in clinical trials: What methods are used in practice?

http://www.wikidata.org/entity/Q38978314

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Bayesian survival analysis in clinical trials: What methods are used in practice?

@en

type

label

Bayesian survival analysis in clinical trials: What methods are used in practice?

@en

prefLabel

Bayesian survival analysis in clinical trials: What methods are used in practice?

@en

P1433

Q38978314-B78BED1B-BBE7-456F-8C84-4692E465BA23

P1476

Q38978314-7CC70A98-C83C-4CD6-9CC9-240E5B56205F

P2093

Q38978314-3B42BBA1-2E07-4115-A48E-A17AE939A4B1

Q38978314-CFC444D0-CE2B-4ABE-BF65-C9C0B2A611BE

P2860

Q38978314-081A4CBE-8FC6-4C0E-BB2B-CEDA640B0387

Q38978314-087AA1BF-E282-4BBC-96EB-D0DE5D93C690

Q38978314-10293E04-FE36-48B2-A97C-7FE5C1D25020

Q38978314-1C0134A7-1A0F-4613-8DA8-80A9D034A2B4

Q38978314-2423B65D-9BD4-4E1E-AA4F-8FB22641045B

Q38978314-2423C438-9726-4AFA-B1DE-05D38785E2A6

Q38978314-244FA791-9254-41EF-98D8-271FB363162F

Q38978314-257960B7-9EEB-4619-8EFC-37DA38D73DD0

Q38978314-26D599B8-3669-409A-9D5F-79D8B1B204C2

Q38978314-2799F13D-064F-4C9F-8256-F72CDF629373

P304

Q38978314-3DC95445-2413-4EE6-A050-04E59A46A922

P31

Q38978314-C2A0D0AB-3B1D-426B-96EE-F93C0A1E377C

P356

Q38978314-0032B60E-E55F-44B7-963B-76947949B28D

P433

Q38978314-C17C7EA5-80BA-4803-B51F-1C4B01FCBFA8

P478

Q38978314-525AFE90-8FBB-4915-90C5-7276CE20BF5F

P50

Q38978314-6DFBDC7D-89E4-400C-AE76-9D0985A776A4

Q38978314-C3BE4282-614E-4DE6-85AA-3F89731F5526

Q38978314-DB5F1B44-BD88-4C61-80C7-4F5DCC3B081B

P577

Q38978314-3875E031-1E26-4B0B-930D-9B0E4DD1481D

P698

Q38978314-54295BC2-3ED6-45B5-8144-4A5BE27CF2D1

P356

1740774516673362

P1433

Clinical Trials

P1476

Bayesian survival analysis in clinical trials: What methods are used in practice?

@en

P2093

Lisa V Hampson

http://www.w3.org/2001/XMLSchema#string

Marie-Cécile Le Deley

http://www.w3.org/2001/XMLSchema#string

P2860

Summarizing historical information on controls in clinical trials

Estimating the Dimension of a Model

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.

Bayesians in clinical trials: asleep at the switch.

Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Use of historical control data for assessing treatment effects in clinical trials.

Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.

Quantifying and documenting prior beliefs in clinical trials.

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

P304

78-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1740774516673362

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Marie-Cécile Le Deley

Gwénaël Le Teuff

P577

2016-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27729499

http://www.w3.org/2001/XMLSchema#string